Myelodysplastic Neoplasms/Syndromes (MDS)

Marie Robin; Carmelo Gurnari

doi:10.1007/978-3-031-44080-9_74

Myelodysplastic Neoplasms/Syndromes (MDS)

Review

In: The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies [Internet]. 8th edition. Cham (CH): Springer; 2024. Chapter 74.

2024 Apr 11.

Authors

Marie Robin¹, Carmelo Gurnari^{2

3}

Book Editors

Anna Sureda¹, Selim Corbacioglu², Raffaella Greco³, Nicolaus Kröger⁴, Enric Carreras⁵

Affiliations

¹ Department of Hematology—Transplantation, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Université de Paris Cité, Paris, France
² Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
³ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA

Book Affiliations

¹ Hematology Department, Institut Català d'Oncologia - Hospital, Barcelona, Spain
² Department of Pediatric Hematology, Oncology and Stem Cell Transplantation University Medical Center, Regensburg, Germany
³ Hematology & Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Milano, Italy
⁴ Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppend, Hamburg, Germany
⁵ Spanish Bone Marrow Donor Registry, Josep Carreras Foundation and Leukemia Research Institute, Catalunya, Barcelona, Spain

Excerpt

Myelodysplastic neoplasms/syndromes (MDS) are a heterogeneous group of clonal stem cell disorders characterized by peripheral cytopenias and dysplastic features in blood and bone marrow.

Sections

Publication types

Review